# Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

> **NCT03415139** · — · UNKNOWN · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 120 (estimated)

## Conditions studied

- Diabetes Mellitus
- Cancer

## Interventions

- **DRUG:** Oral Glucose Tolerance Test (OGTT)
- **DRUG:** 2 OGTTs with and without GLP-1 analogue
- **DRUG:** Hyperglycemic clamp procedure

## Key facts

- **NCT ID:** NCT03415139
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-12
- **Primary completion:** 2023-04
- **Final completion:** 2025-04
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03415139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03415139, "Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03415139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*